Sirolimus in the Treatment of Refractory/Relapsed wAIHA

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 24, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Warm Autoimmune Hemolytic Anemia

Interventions

DRUG

Sirolimus

Oral administration, 1-3 mg/d, sirolimus plasma concentration: 4-15 ng/mL

Trial Locations (1)

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER